News
AGNPF
0.313
NaN%
--
Weekly Report: what happened at AGNPF last week (0706-0710)?
Weekly Report · 14h ago
Weekly Report: what happened at AGNPF last week (0629-0703)?
Weekly Report · 07/06 10:15
Weekly Report: what happened at AGNPF last week (0622-0626)?
Weekly Report · 06/29 10:11
Weekly Report: what happened at AGNPF last week (0615-0619)?
Weekly Report · 06/22 10:19
Weekly Report: what happened at AGNPF last week (0608-0612)?
Weekly Report · 06/15 10:20
Weekly Report: what happened at AGNPF last week (0601-0605)?
Weekly Report · 06/08 10:16
Weekly Report: what happened at AGNPF last week (0525-0529)?
Weekly Report · 06/01 10:20
Grey Matters amends CAD 1 million private placement, extends warrant term to 3 years
PUBT · 05/25 11:05
GREY MATTERS IMPROVES WARRANT TERMS OF PRIVATE PLACEMENT
Reuters · 05/25 11:00
Weekly Report: what happened at AGNPF last week (0518-0522)?
Weekly Report · 05/25 10:23
Grey Matters Health signs LOI with Catalyst MedTech for 200 brain PET scans
PUBT · 05/20 11:05
GREY MATTERS HEALTH SIGNS LOI WITH CATALYST MEDTECH FOR 200 BRAIN PET SCANS FOR ALZHEIMER’S CLINICAL TRIAL AT 2ND NOVASCAN LOCATION PLANNED FOR TAMPA
Reuters · 05/20 11:00
Weekly Report: what happened at AGNPD last week (0511-0515)?
Weekly Report · 05/18 10:23
Grey Matters Health publishes investor presentation on Alzheimer’s diagnosis using brain-optimized PET scans
PUBT · 05/13 06:36
Weekly Report: what happened at AGNPD last week (0504-0508)?
Weekly Report · 05/11 10:20
Grey Matters Health publishes investor presentation on Alzheimer’s diagnosis using brain-optimized PET scans
PUBT · 05/04 23:19
Weekly Report: what happened at AGNPD last week (0427-0501)?
Weekly Report · 05/04 10:18
Grey Matters FY26 Q2 net loss widens to CAD 499,524; six-month loss climbs to CAD 1.1 million
PUBT · 05/01 18:48
Grey Matters Health publishes MD&A for six months ended Feb. 28, 2026
PUBT · 05/01 18:47
Weekly Report: what happened at AGNPD last week (0420-0424)?
Weekly Report · 04/27 10:21
More
Webull provides a variety of real-time AGNPF stock news. You can receive the latest news about GREY MATTERS HEALTH INC, through multiple platforms. This information may help you make smarter investment decisions.
About AGNPF
Grey Matters Health Inc, formerly Algernon Health Inc., is a Canadian healthcare company. The Company is focused on the provision of brain-specific PET scanning services through a planned network of new clinics in North America for the early-stage detection of Alzheimer’s disease, as well as other forms of dementia, epilepsy, neuro-oncology, and movement disorders. It is also the parent company of a private subsidiary called Algernon NeuroScience that has been advancing a psychedelic program investigating a proprietary form of DMT for stroke and traumatic brain injury recovery. The Company also owns a 20% equity position in Seyltx, a private U.S-based drug development company advancing a chronic cough drug called Ifenprodil.